PhD student position (teaching assistantship) in structural biology
We are looking for excellent candidates towards a PhD studentship starting from the academic year 2016/2017 in the Laboratory for Biocrystallography, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven (Gasthuisberg Campus), Belgium (http://pharm.kuleuven.be/Biocrystallography/). KU Leuven is ranked among the top European universities.
The main task will be to perform experimental research within our ongoing efforts to understand the three-dimensional structure of intermediate filaments (IFs). This is a major unresolved problem in the structural cell biology, which is also important for developing approaches to treat diseases caused by mutations in IF proteins. For introduction on the subject see Chernyatina et al (2015) Curr. Opin. Struct. Biol., 32, pp. 65-72, and Herrmann et al (2007) Nature Reviews Molecular Cell Biology, 8(7), 562-573. The activities of the PhD student will include recombinant protein isolation, crystallization, X-ray crystallographic studies, chemical cross-linking as well as additional biophysical and biochemical experiments (Chernyatina et al (2012) Proc. Natl. Acad. Sci. USA, 109, pp. 13620–13625). The working language will be English.
In addition, the PhD student will supervise pharmacy students during the practical exersises on drug formulation. To this end, proficiency in Dutch is an asset.
The applicant should have a MSc diploma in molecular biology, pharmacy or a related field. Previous research experience is a scientific laboratory is desirable. Strong motivation towards scientific research is a must. The initial contract would be one year, to be extended yearly upon a positive evaluation, up to a period of 5 years.
Please address any further questions to Prof. Sergei Strelkov, e-mail: email@example.com. The official application should be done via https://icts.kuleuven.be/apps/jobsite/vacatures/53727144. In addition, please send your detailed CV, list of achievements and names of potential referees to the email address mentioned above.